reports
- GlobalData Healthcare Department
Prothena Corp Plc (PRTA) - Financial Analysis Review
Prothena Corp Plc (PRTA) - Financial Analysis Review Summary Prothena Corp Plc (Prothena) is a biotechnology company that discovers, develops and markets novel antibodies that are indicated for the treatment of diseases associated with amyloid or cell adhesion. The company develops monoclonal antibodies directed specifically at disease-causing proteins. GlobalData's Prothena Corp Plc (PRTA) - Financial Analysis Review provides a comprehensive insight into the company's history, business struc...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.